Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.

@article{Maisel2008TimingOI,
  title={Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.},
  author={Alan S. Maisel and William Franklin Peacock and Neil D. McMullin and Robert Jessie and Gregg C Fonarow and J Michael Wynne and Roger M Mills},
  journal={Journal of the American College of Cardiology},
  year={2008},
  volume={52 7},
  pages={534-40}
}
OBJECTIVES We undertook this analysis to determine whether there is a relationship between the time to measurement of immunoreactive B-type natriuretic peptide (iBNP) and early intervention for acutely decompensated heart failure (ADHF) and whether these variables are associated with morbidity and mortality in ADHF patients. BACKGROUND Although natriuretic peptides (NPs) can aid emergency department (ED) physicians in the diagnosis of ADHF, the relationship between the time to measurement of… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 67 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 17 references

Acute heart failure mortality is dependent on time to intravenous vasoactive administration

  • WF Peacock, CL Emerman, MR Costanza, DB Diercks, M Lopatin, G. Fonarow
  • J Cardiac Fail 2006;12 Suppl 1:S117
  • 2006
1 Excerpt

Admis - sion B - type natriuretic peptide levels and in - hospital mortality in acute decompensated heart failure

  • GC Fonarow, JT Heywood, PA Heidenreich, M Lopatin, CW Yancy
  • JAMA
  • 2005

Similar Papers

Loading similar papers…